Principal Display Panel – Hydralazine Hydrochloride Injection, Usp 20 mg Per mL Carton (20mg Carton V2)
Hydralazine Hydrochloride Injection
Product Images NDC 71288-205
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71288-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel – Hydralazine Hydrochloride Injection, Usp 20 mg Per mL Vial (20mg Vial V2)
This text provides information about Hydralazine Hydrochloride Injection, USP, which is intended for intramuscular or intravenous use. Each vial contains mg per mL of the medication and is a single-dose vial. The recommended storage conditions are at a controlled room temperature between 20°to 25°C (68°F to 77°F). It also mentions the manufacturer as Meitheal Pharmaceuticals based in Chicago, IL, USA. Additionally, it advises discarding any unused portion and referring to the package insert for the usual dosage.*
Structural Formula (Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
